Hui Li

机构：Local Initiatives Support Corporation, Peking University, NARI Group (China), Peking University Third Hospital · ORCID：0000-0002-2108-0201

发表论文 207 篇 · 总被引 4339 次 · h-index 34

代表论文

• Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials (2025 · The Lancet · 被引 40)
• Oligodendroglial precursor cells modulate immune response and early demyelination in a murine model of multiple sclerosis (2025 · Science Translational Medicine · 被引 25)
• Crocin-1 laden thermosensitive chitosan-based hydrogel with smart anti-inflammatory performance for severe full-thickness burn wound therapeutics (2024 · Carbohydrate Polymers · 被引 23)
• Prevalence of common upper gastrointestinal diseases in Chinese adults aged 18–64 years (2024 · 中国科学通报：英文版 · 被引 20)
• The endosomal–vacuolar transport system acts as a docking platform for the Pmk1 MAP kinase signaling pathway in Magnaporthe oryzae (2024 · New Phytologist · 被引 16)
• A multilayered regulatory network mediated by protein phosphatase 4 controls carbon catabolite repression and de-repression in Magnaporthe oryzae (2025 · Communications Biology · 被引 13)